Helicobacter Pylori Infection and Associated Gastrointestinal Disorders

Helicobacter pylori is a highly prevalent gastric pathogen that persistently colonises the human stomach, provoking chronic gastritis, peptic ulceration and, in a subset of infected individuals, gastric carcinoma. Its helical shape and flagellar motility facilitate penetration of the mucus layer and adherence to epithelial cells, while urease production neutralises local acidity. The bacterium’s repertoire of virulence factors includes the cytotoxin VacA, which induces intracellular vacuolation and mitochondrial dysfunction, and the CagA oncoprotein, delivered via a type IV secretion system, which disrupts host signalling and promotes pro-inflammatory cascades. Geographic variation in strain genotype correlates with differing disease risks, reflecting co-evolutionary history with human populations. Emerging concerns over antibiotic resistance have underscored the need for novel eradication strategies, including vaccine development and host-directed therapies. Recent advances in our understanding of host–microbe interactions, bacterial population structure and the molecular basis of mucosal adaptation are informing refined diagnostic markers and personalised treatment regimens. The global burden of H. pylori-associated disease and its role in gastric carcinogenesis position this organism at the forefront of translational gastroenterological research.

Research from Nature Portfolio

Genomic analysis has revealed a previously unrecognised ‘Hardy’ ecospecies of H. pylori that diverged early in human evolution and carries distinct outer membrane protein alleles and an alternative iron-dependent urease. This finding highlights stable adaptive strategies within gastric bacterial populations, even amid ongoing genetic exchange. Complementing this, a large-scale genome project comprising over a thousand clinical isolates worldwide has delineated the global population structure of H. pylori, identifying novel subpopulations with variable pathogenicity islands and virulence gene profiles. These datasets provide a valuable resource for tracing disease-associated lineages and offer new targets for therapeutic intervention.

Helicobacter Pylori Infection and Associated Gastrointestinal Disorders publication trend

The graph below shows the total number of articles in helicobacter pylori infection and associated gastrointestinal disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Adhesin: A bacterial surface protein that mediates attachment to host epithelial receptors.

CagA: Cytotoxin-associated gene A, a protein injected into host cells via a type IV secretion system that perturbs signalling pathways.

Type IV secretion system: A multiprotein complex used by bacteria to translocate effector molecules into host cells.

Two-component system (ArsRS): A bacterial regulatory circuit comprising a sensor kinase (ArsS) and response regulator (ArsR) that responds to environmental pH.

Vacuolating cytotoxin (VacA): A secreted toxin that induces large intracellular vacuoles and affects mitochondrial and endosomal function.

References

1. An ancient ecospecies of Helicobacter pylori. Nature (2024).
2. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes. Nature Communications (2023).
3. Molecular insights into the fine-tuning of pH-dependent ArsR-mediated regulation of the SabA adhesin in Helicobacter pylori. Nucleic Acids Research (2024).
4. Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity. Toxins (2019).